Last reviewed · How we verify

A collection of maternal plasma and serum

Assistance Publique - Hôpitaux de Paris · Phase 2 active Biologic Quality 0/100

A collection of maternal plasma and serum is a Biologic drug developed by Assistance Publique - Hôpitaux de Paris. It is currently in Phase 2 development.

At a glance

Generic nameA collection of maternal plasma and serum
SponsorAssistance Publique - Hôpitaux de Paris
ModalityBiologic
PhasePhase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about A collection of maternal plasma and serum

What is A collection of maternal plasma and serum?

A collection of maternal plasma and serum is a Biologic drug developed by Assistance Publique - Hôpitaux de Paris.

Who makes A collection of maternal plasma and serum?

A collection of maternal plasma and serum is developed by Assistance Publique - Hôpitaux de Paris (see full Assistance Publique - Hôpitaux de Paris pipeline at /company/assistance-publique-h-pitaux-de-paris).

What development phase is A collection of maternal plasma and serum in?

A collection of maternal plasma and serum is in Phase 2.

Related